Related Experiment Video
Updated: Jun 4, 2026
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
[Surgical treatment of primary pulmonary low-grade malignant carcinoma]
Ming Han1, Junzhong Ruan, Xiuyi Zhi
1Department of Thoracic Surgery, Thoracic Tumors Hospital, Beijing 101149, P.R.China.
Background:
To arrive at a rational diagnosis and effective surgical treatment of primary pulmonary low-grade malignant carcinoma.
Methods:
Eighty-nine patients with primary pulmonary low-grade malignant carcinoma received surgical treatment from 1956 to 2000.
Results:
Out of the 89 patients, 54 were bronchial carcinoid, 18 were mucoepidermoid cancer, and 17 were adenoid cystic carcinoma. The operative procedures included resection of tracheal carcinoma in 3, lobectomy in 49, sleeve lobectomy in 14, total pneumonectomy in 14, and wedge pneumonectomy in 6. All patients were complaint free. The 5-year survival rates of bronchial carcinoid and adenoid cystic carcinoma were 91.3% and 70.6% respectively, and no patients with bronchial mucoepidermoid cancer died until now.
Conclusions:
Bronchial carcinoid, adenoid cystic carcinoma and mucoepidermoid cancer are a series of primary pulmonary carcinoma of low malignant potential, whose predilection sites are main or lobe bronchi, and clinical symptoms are repeated infection of the lung or intermittent hemoptysis. The diagnosis depends on radiography or CT scan of chest and bronchofiberscopy. The operation is most important, and whose procedure is lobectomy or sleeve lobectomy mainly.
